A

American Research Institute | Cutler Bay, FL

Research site
(Unclaimed)
Location
18951 SW 106th Ave, Suite B-110, Cutler Bay, Florida, United States of America
Site insights

Top conditions

Crohn Disease (3 trials)

Gastroparesis (2 trials)

Fatty Liver (2 trials)

Non-alcoholic Fatty Liver Disease (2 trials)

Lung Cancer (1 trial)

Top treatments

Ozanimod
Relamorelin
Lanifibranor
TVB-2640

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 9
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337

This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.

Enrolling
Crohn Disease
Drug: Ozanimod
Other: Placebo

This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.

Enrolling
Crohn Disease
Drug: Ozanimod

Trial sponsors

Celgene logo

Celgene (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems